SmithRx Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
550
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$60M
- Investors
-
18
SmithRx General Information
Description
Operator of a pharmacy benefit manager platform intended to focus on transparency, efficiency, and data analytics. The company's platform offers maximum flexibility, control, and visibility of pharmacy benefits data for employer customers and partners, enabling members to benefit from the company's clinical programs, alternative sourcing, and transparent pricing to easily manage their prescription benefits and reduce overall drug spending.
Contact Information
Website
www.smithrx.comCorporate Office
- 300 Brannan Street
- Suite 601
- San Francisco, CA 94107
- United States
Corporate Office
- 300 Brannan Street
- Suite 601
- San Francisco, CA 94107
- United States
SmithRx Timeline
SmithRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 23-Jan-2024 | $60M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series B) | 02-Feb-2022 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 16-Apr-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A2) | 31-Jul-2018 | Completed | Generating Revenue | |||
| 3. Debt - General | 01-May-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 11-Jan-2018 | $9M | $12M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 31-Mar-2017 | $3M | $3M | Completed | Generating Revenue |
SmithRx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 3,160,387 | $0.000100 | $0.08 | $0.97 | $0.97 | 1x | $0.97 | 3.25% |
| Series A | 6,730,467 | $0.000100 | $0.11 | $1.34 | $1.34 | 1x | $1.34 | 6.93% |
SmithRx Comparisons
Industry
Financing
Details
SmithRx Competitors (28)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rightway | Venture Capital-Backed | New York, NY | ||||
| Truveris | Venture Capital-Backed | Wilmington, DE | ||||
| Capital Rx | Venture Capital-Backed | New York, NY | ||||
| Health Catalyst | Formerly VC-backed | South Jordan, UT | ||||
| OptumRx | Corporate Backed or Acquired | Dallas, TX |
SmithRx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SmithRx Executive Team (9)
| Name | Title | Board Seat |
|---|---|---|
| Jacob Frenz | Founder, Chief Executive Officer & Board Member | |
| Ethan Fassett | Advisor |
SmithRx Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Bryan Roberts Ph.D | Venrock | Board Member | |
| Jacob Frenz | SmithRx | Founder, Chief Executive Officer & Board Member | |
| Matthew McKnight | Self | Board Member |
SmithRx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SmithRx Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 10X Group | Venture Capital | Minority | ||
| Venrock | Venture Capital | Minority | ||
| FourCities Capital | Venture Capital | Minority | ||
| Kalyan Vepuri | Angel (individual) | Minority | ||
| MCVC Partners | Venture Capital | Minority |
SmithRx Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| WithMe Health | 01-Jan-2024 | Enterprise Systems (Healthcare) | |||
| WhiteWell Rx | 10-Jan-2017 | Merger/Acquisition | Pharmaceuticals |
SmithRx FAQs
-
When was SmithRx founded?
SmithRx was founded in 2016.
-
Who is the founder of SmithRx?
Jacob Frenz is the founder of SmithRx.
-
Who is the CEO of SmithRx?
Jacob Frenz is the CEO of SmithRx.
-
Where is SmithRx headquartered?
SmithRx is headquartered in San Francisco, CA.
-
What is the size of SmithRx?
SmithRx has 550 total employees.
-
What industry is SmithRx in?
SmithRx’s primary industry is Other Healthcare Technology Systems.
-
Is SmithRx a private or public company?
SmithRx is a Private company.
-
What is the current valuation of SmithRx?
The current valuation of SmithRx is .
-
What is SmithRx’s current revenue?
The current revenue for SmithRx is .
-
How much funding has SmithRx raised over time?
SmithRx has raised $110M.
-
Who are SmithRx’s investors?
10X Group, Venrock, FourCities Capital, Kalyan Vepuri, and MCVC Partners are 5 of 18 investors who have invested in SmithRx.
-
Who are SmithRx’s competitors?
Rightway, Truveris, Capital Rx, Health Catalyst, and OptumRx are some of the 28 competitors of SmithRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
